Ravi B. Parikh, MD, MPP, FACP
-
RoleGenitourinary Medical Oncology
-
Research Program
-
Practicing Since2019
Background
Ravi B. Parikh, MD, MPP, is a board-certified medical oncologist specializing in the treatment of genitourinary cancers. Dr. Parikh is an attending physician practicing at Winship Cancer Institute at Emory Midtown.
Dr. Parikh is an associate professor in the Department of Hematology and Medical Oncology at the Emory University School of Medicine. He serves as medical director of the Winship Data and Technology Applications Shared Resource at Winship Cancer Institute of Emory University. In this role, he is responsible for its overall strategic scientific management and operational oversight. He works closely with leadership to develop and integrate artificial intelligence (AI) applications to improve the care of Winship patients with cancer.
Dr. Parikh received his medical degree at Harvard Medical School and his Master of Public Policy at the John F. Kennedy School of Government. He completed his residency in internal medicine at Brigham and Women’s Hospital and his fellowship in hematology and oncology at the University of Pennsylvania.
Titles & Roles
-
Associate Professor, Department of Hematology and Medical OncologyEmory University School of Medicine
-
Medical Director, Winship Data and Technology Applications Shared ResourceWinship Cancer Institute of Emory University
Education & Training
Education
- Fellowship, Hematology/Oncology, 2019University of Pennsylvania Health System - Hospital of the University of Pennsylvania
- Residency, Internal Medicine, 2017Brigham and Women's Hospital
- Internship, Internal Medicine, 2015Brigham and Women's Hospital
- Medical Education, MD, 2014Harvard Medical School
Board Certifications
- Medical OncologyAmerican Board of Internal Medicine, 2019Internal MedicineAmerican Board of Internal Medicine, 2017
Professional Memberships
- American College of Physicians
- American Society of Clinical Oncology
Research
Dr. Parikh directs the Human-Algorithm Collaboration Lab, an NIH-funded multidisciplinary laboratory focusing on developing and testing algorithm-driven interventions in cancer care and serious illness. He has led prospective trials of AI-based interventions to increase access to palliative and supportive care, enable earlier diagnosis of cancer and cancer-related adverse events, and streamline clinical trial operations. In addition, he maintains a funded portfolio on emerging health care AI topics, including algorithmic bias, AI-based risk adjustment, explainable AI, wearables, human-machine collaboration, and AI regulation and policy.
Publications
Dr. Parikh's research has been published in leading journals, such as Science, the New England Journal of Medicine, the Journal of Clinical Oncology and the Journal of the American Medical Association. He is a consultant editor at the Journal of Clinical Oncology and sits on the board of directors of the Coalition to Transform Advanced Care.
Title/Journal Authors Publication Date Generative AI in Medicine - Evaluating Progress and Challenges.
The New England journal of medicine
TM Maddox, P Embí, J Gerhart, J Goldsack, RB Parikh, TC Sarich 04/10/2025 Racial Bias in Clinical and Population Health Algorithms: A Critical Review of Current Debates.
Annual review of public health
M Coots, KA Linn, S Goel, AS Navathe, RB Parikh 04/01/2025 Journal of geriatric oncology
G Aleixo, T Patel, J Ani, WJ Ferrell, E Dotan, SU Takvorian, GR Williams, RB Parikh, R Sedhom 03/01/2025 Inpatient Immunotherapy Outcomes Study: A Multicenter Retrospective Analysis.
JCO oncology practice
F Riaz, JL Vaughn, H Zhu, JC Dickerson, HE Sayegh, S Brongiel, E Baldwin, MW Kier, J Zaemes, C Hearn, O Abdelghany, RB Cohen, RB Parikh, JE Reuss, E Prsic, DB Doroshow 02/12/2025 Algorithm-Based Palliative Care in Patients With Cancer: A Cluster Randomized Clinical Trial.
JAMA network open
RB Parikh, WJ Ferrell, Y Li, J Chen, L Bilbrey, N Johnson, J White, R Sedhom, NR Dickson, S Schleicher, JE Bekelman, S Mudumbi 02/03/2025 Chemoimmunotherapy vs Immunotherapy Monotherapy Receipt in Advanced Non-Small Cell Lung Cancer.
JAMA network open
VS Ahluwalia, RB Parikh 02/03/2025 medRxiv : the preprint server for health sciences
SE Hegarty, KA Linn, H Zhang, S Teeple, PS Albert, RB Parikh, K Courtright, DM Kent, J Chen 02/02/2025 Nature medicine
X Orcutt, K Chen, R Mamtani, Q Long, RB Parikh 02/01/2025 Explainable Machine Learning to Predict Treatment Response in Advanced Non-Small Cell Lung Cancer.
JCO clinical cancer informatics
VS Ahluwalia, RB Parikh 01/01/2025 Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.